We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples

By LabMedica International staff writers
Posted on 17 Apr 2024
Print article
Image: AI played critical role in intestinal worm infection screening among children in Kenya (Photo courtesy of University of Helsinki)
Image: AI played critical role in intestinal worm infection screening among children in Kenya (Photo courtesy of University of Helsinki)

Infections from soil-transmitted helminths (STHs), commonly known as intestinal parasitic worms, are among the most widespread neglected tropical diseases and impose a significant health burden in low- and middle-income countries, particularly among school-aged children. These infections often lead to chronic health issues that can cause disability, social stigma, and for their substantial economic impacts on communities. STHs are notorious role in nutrient loss, which can contribute to neurocognitive impairments, stunted growth and development, and persistent fatigue in affected children. Additionally, these parasites are a major cause of morbidity and complications during pregnancy. The standard diagnostic method for STHs involves manual microscopy, which requires up to 10 minutes per slide and is hindered by a lack of skilled professionals and access to necessary equipment and lab infrastructure in highly affected regions. There is a pressing need for improved diagnostic techniques, particularly for detecting infections of mild intensity, to effectively manage and aim for the elimination of STHs as a public health concern. Now, an artificial intelligence (AI) microscopy system has been shown to accurately identify intestinal worm infections, especially light-intensity infections that could be overlooked when using manual microscopy.

The new study by a multi-institutional team of specialists from the Karolinska Institute (Stockholm, Sweden) and University of Helsinki (Helsinki, Finland) marked the first clinical trial of the system to detect worm infections in a remote setting with whole-slide images. The study was carried out in rural areas of Kwale County, Kenya, where there is a high prevalence of STHs among children. During the study, 1,335 school-aged children were screened using the deep learning-based system for parasitic worm egg detection, with results compared against those obtained through expert manual microscopy.

The analysis of digitally scanned stool samples using the deep learning system demonstrated high diagnostic accuracy in identifying three common types of parasitic worms: Ascaris lumbricoides (giant roundworm), Trichuris trichiura (whipworm), and hookworm (Ancylostoma duodenale or Necator americanus). The AI was able to detect between 76% and 92% of the infections identified by trained lab technicians, depending on the type of worm. Notably, the AI system identified a significant number of light-intensity infections that were missed in manual microscopy evaluations. In fact, in 79 samples (10% of the total), which were initially determined to be negative by manual microscopy, the AI system detected the presence of parasitic worm eggs. Moreover, the AI system provides a digital record of each sample that can be preserved for further analysis, offering a significant advantage over human samples, which typically dry out within hours and become more challenging for further analysis.

“We have shown that we can use our testing in a resource-limited setting and get high accuracy. Our method was especially efficient in light-intensity infections,” said Principal Investigator Professor Johan Lundin, MD, PhD, from the Karolinska Institutet. “With AI, once our sample is digitised, it takes just a few second and looks at the entire sample and is able to very accurately find the parasite eggs.”

Related Links:
Karolinska Institute
University of Helsinki

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hepatitis B Assay
Monolisa HBs Ag ULTRA Assay
New
Isothermal Amplification Technology
SIBA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.